NR1H4 and inflammatory bowel disease: Reduced levels of unconjugated and secondary bile acids, such as CDCA and LCA, have been associated with impaired FXR activation, which can compromise anti-inflammatory pathways and contribute to IBD pathogenesis [49,50].